A systematic review on potential mechanisms of minocycline in kidney diseases

Hamed Haghi-Aminjan1, Mohammad Hossein Asghari1, Mohammad Hadi Goharbari1

  • 1Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Insights

Minocycline, an antibiotic, shows promise in protecting kidneys by reducing apoptosis, inflammation, and oxidative stress. Further research is needed to confirm its safety and efficacy for treating kidney diseases.

Area of Science:

  • Nephrology
  • Pharmacology
  • Cell Biology

Background:

  • Kidney diseases are a significant cause of mortality requiring specialized care.
  • Minocycline, an antibiotic, exhibits cytoprotective effects beyond its antibacterial properties.
  • Understanding these mechanisms is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To elucidate the cytoprotective mechanisms of minocycline relevant to kidney protection.
  • To systematically review the existing literature on minocycline's effects in renal diseases.

Main Methods:

  • A systematic literature search was conducted in PubMed, Scopus, and Web of Science up to August 2016.
  • Inclusion criteria focused on studies investigating minocycline in renal diseases, regardless of subject (in-vivo/in-vitro, human/animal).
  • PRISMA guidelines were followed for study selection, resulting in the analysis of relevant articles.

Main Results:

  • Key factors in kidney disease progression include apoptosis, oxidative stress, mitochondrial dysfunction, and inflammation.
  • Minocycline demonstrated protective effects through anti-apoptotic, free radical scavenging, anti-inflammatory actions, and modulation of mitochondrial function.
  • Inhibition of matrix metalloproteinase was also identified as a protective mechanism.

Conclusions:

  • Minocycline exhibits significant potential in ameliorating renal malfunctions through multiple cytoprotective pathways.
  • The findings support minocycline as a potential therapeutic agent for kidney diseases.
  • Further investigation into potential adverse effects of minocycline is warranted before clinical application.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
397
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
288
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.4K
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
285
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
539
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
588